Blood Glucose Awareness Training (BGAT-2)

Long-term benefits

  1. Daniel J. Cox, PHD1,
  2. Linda Gonder-Frederick, PHD1,
  3. William Polonsky, PHD2,
  4. David Schlundt, PHD3,
  5. Boris Kovatchev, PHD1 and
  6. William Clarke, MD1
  1. 1University of Virginia Health Sciences Center, Charlottesville, Virginia
  2. 2Joslin Diabetes Center, Boston
  3. 3the Psychology Department, Vanderbilt University

    Abstract

    OBJECTIVE—Blood glucose awareness training (BGAT) has been shown to improve awareness of blood glucose (BG) fluctuations among adults with type 1 diabetes. This study investigates the long-term (12-month) benefits of BGAT-2.

    RESEARCH DESIGN AND METHODS—A total of 73 adults with type 1 diabetes participated in a 6-month repeated baseline design with a 12-month follow-up. At 6 months and 1 month before BGAT-2 and at 1, 6, and 12 months after BGAT-2, subjects used a handheld computer for 50 trials and completed psychological tests. Throughout assessment, subjects completed diaries, recording occurrences of diabetic ketoacidosis, severe hypoglycemia, and motor vehicle violations. During follow-up, 50% of the subjects received booster training.

    RESULTS—During the first and last halves of both the baseline period and the follow-up period, dependent variables were generally stable. However, from baseline to follow-up, BGAT-2 led to 1) improved detection of hypoglycemia and hyperglycemia; 2) improved judgment regarding when to lower high BG, raise low BG, and not drive while hypoglycemic; 3) reduction in occurrence of diabetic ketoacidosis, severe hypoglycemia, and motor vehicle violations; and 4) improvement in terms of worry about hypoglycemia, quality of life, and diabetes knowledge. Reduction in severe hypoglycemia was not associated with a worsening of metabolic control (HbA1). The presence or absence of booster training did not differentially affect these benefits.

    CONCLUSION—BGAT has sustained broad-ranging benefits, independent of booster intervention.

    Footnotes

    • Address correspondence and reprint requests to Daniel J. Cox, Behavioral Medicine Center, Box 223, University of Virginia Health Sciences Center, Charlottesville, VA 22908.

      Received for publication 3 April 2000 and accepted in revised form 30 November 2000.

      A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    « Previous | Next Article »Table of Contents